ClinicalTrials.gov
ClinicalTrials.gov Menu

Sentinel Lymph Node Technique in Multifocal Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00417495
Recruitment Status : Completed
First Posted : January 1, 2007
Last Update Posted : January 6, 2016
Sponsor:
Information provided by:
Centre Oscar Lambret

Brief Summary:
The scope of this trial is to assess the Sentinel Lymph Node Technique in Multifocal Breast Cancer

Condition or disease Intervention/treatment Phase
Breast Cancer Behavioral: Sentinel Lymph Node Technique Phase 2

Detailed Description:

The sentinel lymph node is located preferentially by:

  • association of subareolar injection of technecium and blue dye
  • or, in case of blue dye allergy, by the subareolar injection of technecium only
  • or, in case of no possibility of radioactive isotope subareolar injection , by blue dye injection only This procedures are made the day before the surgery or the day of the surgery
  • This procedure is immediately follows by complete axillary dissection during breast surgery
  • The anatomopathologic analysis of the 2 samples (sentinel lymph node and axillary dissection) and the histologic confirmation on the removed tumor of the multifocal nature of the breast cancer correspond to the end of the study for the patient.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 216 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Interest of Sentinel Lymph Node Technique in Women With a Multifocal Breast Cancer - IGASSU-0502
Study Start Date : March 2006
Actual Primary Completion Date : September 2008
Actual Study Completion Date : September 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer




Primary Outcome Measures :
  1. detection rate of sentinel nodes [ Time Frame: surgery ]

Secondary Outcome Measures :
  1. number of sentinel nodes removed [ Time Frame: surgery ]
  2. localisation of the sentinel nodes [ Time Frame: surgery ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Multifocal invasive breast cancer
  • At least 2 focuses (clinically and/or by mammography or ultrasound)
  • Proven by pre-surgical histology (on 1 focus at least)
  • Age > 18 years old
  • Clinically negative axillary lymph nodes
  • No treatment before surgery
  • Signature of written informed consent

Exclusion Criteria:

  • Multifocality proven after surgery
  • Non invasive breast cancer
  • Inflammatory breast cancer
  • Axillary lymph node
  • Metastatic disease
  • Previous homolateral breast cancer
  • Dementia or alterated mental status
  • Pregnant or lactating woman

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00417495


Locations
France
Centre Hospitalier Universitaire
Amiens, France, 80054
Centre Paul Papin
Angers, France, 49933
Institut Bergonie
Bordeaux, France, 33076
Centre Jean Perrin
Clermont-Ferrand, France, 63011
Clinique de Flandre
Coudekerque Branche, France, 59210
Centre Georges-Francois LECLERCQ
Dijon, France, 21000
Centre Oscar Lambret
Lille, France, 59020
Centre Leon Berard
Lyon, France, 69373
Institut Paoli Calmettes
Marseille, France, 130009
CRLC Val d'Aurelle
Montpellier, France, 34298
Hôpital Lariboisière
Paris, France, 75010
Hopital Tenon
Paris, France, 75970
Centre Eugene Marquis
Rennes, France, 35042
Centre Henri Becquerel
Rouen, France, 76038
Centre Hospitalier Sud Léman Valsérine
SAINT JULIEN en GENEVOIS, France, 74167
Centre Rene Gauducheau
Saint-Herblain, France, 44805
Hôpital Georges PIANTA
THONON-les-BAINS, France, 74203
Centre Claudius Regaud
Toulouse, France, 31052
Centre Hospitalier
Valenciennes, France, 59300
Institut Gustave Roussy
Villejuif, France, 94808
Sponsors and Collaborators
Centre Oscar Lambret
Investigators
Principal Investigator: GIARD Sylvia, MD Centre Oscar Lambret

Responsible Party: Sylvia GIARD, MD, PhD, Centre Oscar Lambret - LILLE (France)
ClinicalTrials.gov Identifier: NCT00417495     History of Changes
Other Study ID Numbers: IGASSU 0502
First Posted: January 1, 2007    Key Record Dates
Last Update Posted: January 6, 2016
Last Verified: January 2016

Keywords provided by Centre Oscar Lambret:
adenocarcinoma, breast, multifocal lesions, surgery

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases